Inventiva (IVEVF) Shares Outstanding (2019 - 2025)
Inventiva (IVEVF) posted Shares Outstanding (Entity) of $193.2 million for Q4 2025, up 223.25% on a QoQ basis from $59.8 million in Q4 2024, and up 223.25% year-over-year from $59.8 million in Q4 2024.
Analysis
Inventiva (IVEVF) Shares Outstanding (2019 - 2025) Analysis & Trends
Inventiva has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $193.2 million in Q4 2025.
- On a quarterly basis, Shares Outstanding (Entity) rose 223.25% year-over-year to $193.2 million in Q4 2025; TTM through Dec 2025 was $193.2 million, a 223.25% increase from a year earlier, with the FY2025 full-year figure at $193.2 million, up 223.25% from the prior year.
- Shares Outstanding (Entity) was $193.2 million for Q4 2025 at Inventiva, up from $59.8 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $193.2 million in Q4 2025, with the low at $40.9 million in Q4 2021.
- Average Shares Outstanding (Entity) over 5 years is $77.6 million, with a median of $52.1 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) climbed 3.08% in 2022, then jumped 223.25% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $40.9 million in 2021, then advanced by 3.08% to $42.1 million in 2022, then climbed by 23.69% to $52.1 million in 2023, then climbed by 14.7% to $59.8 million in 2024, then surged by 223.25% to $193.2 million in 2025.
- The last three Shares Outstanding (Entity) figures came in at $193.2 million (Q4 2025), $59.8 million (Q4 2024), and $52.1 million (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 1.22 Bn |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | 210.89 Mn |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 200.38 Mn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 42.60 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | 186.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 186.80 Mn |
| Jun 30, 2025 | 59.78 Mn |
| Dec 31, 2024 | 59.78 Mn |
| Jun 30, 2024 | 45.35 Mn |
| Dec 31, 2023 | 45.35 Mn |
| Jun 30, 2023 | 41.45 Mn |
| Dec 31, 2022 | 41.45 Mn |
| Sep 22, 2022 | 39.17 Mn |
| Jun 30, 2022 | 39.17 Mn |
| Dec 31, 2021 | 39.17 Mn |
| Jun 30, 2021 | 33.87 Mn |
| Mar 31, 2021 | 33.87 Mn |
| Dec 31, 2020 | 33.87 Mn |
| Jun 30, 2020 | 23.52 Mn |
| Mar 31, 2020 | 23.52 Mn |
| Dec 31, 2019 | 23.52 Mn |